BiotechTube
Home/Mayne Pharma Group/Aaron Gray
AG

Aaron Gray

Chief Executive Officer

Mayne Pharma Group

Therapeutic Areas

Women's HealthDermatology

Mayne Pharma Group Pipeline

DrugIndicationPhase
Nextstellis®Oral ContraceptionMarketed
EPSOLAY®Papulopustular RosaceaMarketed
TWYNEO®Acne VulgarisMarketed
Adelaide Apothecary PortfolioVarious Dermatological ConditionsMarketed
Generic & 505(b)(2) PipelineVarious (Women's Health, Dermatology)Development

Leadership Team at Mayne Pharma Group

SP
Shawn Patrick O'Brien
Former Chief Executive Officer and Managing Director
View full Mayne Pharma Group profile